IIC
VIVO

Integrated Investment Consultants’s Meridian Bioscience Inc VIVO Stock Holding History

Integrated Investment Consultants’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,622
Closed -$354K – 253
2022
Q2 		$354K Sell
11,622
-30
-0.3% -$811 0.13% 125
2022
Q1 		$302K Buy
11,652
+278
+2% +$6.61K 0.08% 222
2021
Q4 		$232K Sell
11,374
-1
-0% -$19 0.06% 267
2021
Q3 		$219K Buy
11,375
+133
+1% +$2.65K 0.06% 264
2021
Q2 		$249K Buy
+11,242
New +$238K 0.07% 235

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integrated Investment Consultants's VIVO Position: Q3 2022 in Review

Integrated Investment Consultants sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 11,622 shares — an estimated $354K sold.

Integrated Investment Consultants first reported a position in VIVO in Q2 2021 and held it in 5 quarters. The position peaked at $354K in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Integrated Investment Consultants reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Integrated Investment Consultants sold 11,622 Meridian Bioscience Inc shares in Q3 2022, an estimated $354K.
  • Integrated Investment Consultants first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 5 quarters.
  • Integrated Investment Consultants's Meridian Bioscience Inc position peaked at $354K in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Integrated Investment Consultants's 13F filing for Q3 2022, filed 21 Nov 2022.